Display options
Cite
Cussans A, Harvey G, Kemple T, et al. Environmental impact ratings that could drive positive environmental changes in the manufacture and use of pharmaceuticals. BJGP Open. 2021;doi: 10.3399/BJGPO.2021.0214.
Cussans, A., Harvey, G., Kemple, T., Lyons, T., Tomson, M., & Wilson, A. (2021). Environmental impact ratings that could drive positive environmental changes in the manufacture and use of pharmaceuticals. BJGP open, . https://doi.org/10.3399/BJGPO.2021.0214
Cussans, Amelia, et al. "Environmental impact ratings that could drive positive environmental changes in the manufacture and use of pharmaceuticals." BJGP open vol. (2021). doi: https://doi.org/10.3399/BJGPO.2021.0214
Cussans A, Harvey G, Kemple T, Lyons T, Tomson M, Wilson A. Environmental impact ratings that could drive positive environmental changes in the manufacture and use of pharmaceuticals. BJGP Open. 2021 Dec 22; doi: 10.3399/BJGPO.2021.0214. Epub 2021 Dec 22. PMID: 34937691.
Copy Download .nbib Format: NLM
Share it on

BJGP Open. 2021 Dec 22; doi: 10.3399/BJGPO.2021.0214. Epub 2021 Dec 22.

Environmental impact ratings that could drive positive environmental changes in the manufacture and use of pharmaceuticals.

BJGP open

Amelia Cussans, Guy Harvey, Terry Kemple, Tracy Lyons, Mike Tomson, Angela Wilson

Affiliations

  1. Central North West London NHS Trust, Mental Health Centre, London, United Kingdom.
  2. Cumbria Northumberland Tyne and Wear NHS Trust, Newcastle upon Tyne, United Kingdom.
  3. UK Health Alliance for Climate Change, London, United Kingdom [email protected].
  4. Department of Radiology, Pharmacy, University Hospital Dorset NHS Foundation trust, Poole, United Kingdom.
  5. Oxfordshire Clinical Commissioning Group, Oxford, United Kingdom.

PMID: 34937691 DOI: 10.3399/BJGPO.2021.0214

[No abstract available.]

Keywords: Quality assurance; environment; pharmaceuticals

Publication Types